To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission
Study limitation reported by the research below: “Only an abstract or title is available for this paper (published 2026-10-12); no full text was provided, so key results, sample size, and specific findings cannot be extracted.”